Clinical trial
Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ACZ885 in Healthy…
NCT00421226 · Novartis, Industry · Completed
Key facts
| NCT number | NCT00421226 |
|---|---|
| Title | Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ACZ885 in Healthy Japanese Male Volunteers |
| Official title | A Randomized, Double-blind, Placebo-controlled, Single Ascending Dose Study to Demonstrate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ACZ885 Administered as Intravenous Infusion and Subcutaneous Injection in Japanese Healthy Volunteers |
| Lead sponsor | Novartis, Industry |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Healthy |
| Intervention type | Drug |
| Interventions | ACZ885 |
| Enrollment | 48 |
| Start date | Dec 1, 2006 |
| Primary completion | Oct 1, 2007 |
| Completion | Dec 1, 2007 |
| First posted | Jan 11, 2007 |
| Last update posted | Apr 30, 2012 |
| Countries | Japan |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: